Table of Contents

company-logo

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Adverum Biotechnologies Dividend Announcement

• Adverum Biotechnologies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Adverum Biotechnologies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Adverum Biotechnologies Dividend History

Adverum Biotechnologies Dividend Yield

Adverum Biotechnologies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Adverum Biotechnologies stock? Use our calculator to estimate your expected dividend yield:

Adverum Biotechnologies Financial Ratios

P/E ratio-1.36
PEG ratio-4.41
P/B ratio0.89
ROE-65.14%
Payout ratio0.00%
Current ratio5.82
Quick ratio5.82
Cash Ratio3.36

Adverum Biotechnologies Dividend FAQ

Does Adverum Biotechnologies stock pay dividends?
Adverum Biotechnologies does not currently pay dividends to its shareholders.
Has Adverum Biotechnologies ever paid a dividend?
No, Adverum Biotechnologies has no a history of paying dividends to its shareholders. Adverum Biotechnologies is not known for its dividend payments.
Why doesn't Adverum Biotechnologies pay dividends?
There are several potential reasons why Adverum Biotechnologies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Adverum Biotechnologies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Adverum Biotechnologies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Adverum Biotechnologies a dividend aristocrat?
Adverum Biotechnologies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Adverum Biotechnologies a dividend king?
Adverum Biotechnologies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Adverum Biotechnologies a dividend stock?
No, Adverum Biotechnologies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Adverum Biotechnologies stocks?
To buy Adverum Biotechnologies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Adverum Biotechnologies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.